Biodexa Pharmaceuticals Plc (LON:MTPH – Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 18 ($0.24) and traded as low as GBX 12.50 ($0.17). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.24), with a volume of 73,672 shares trading hands.
Biodexa Pharmaceuticals Stock Up 1,794.7 %
The company has a debt-to-equity ratio of 9.52, a quick ratio of 5.28 and a current ratio of 5.28. The company’s fifty day moving average price is GBX 18 and its 200-day moving average price is GBX 18. The stock has a market cap of £31.20 million, a P/E ratio of -21.95 and a beta of 1.22.
About Biodexa Pharmaceuticals
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection.
Further Reading
- Five stocks we like better than Biodexa Pharmaceuticals
- How to Invest in Biotech Stocks
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Consumer Staples Stocks, Explained
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Biodexa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodexa Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.